The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Tsao et al., N Engl J Med 353(2):133-144 July 14, 2005.

Correction
PreviousPrevious
Volume 355:1746 October 19, 2006 Number 16

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Tsao, M.-S.
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome . On page 139, the second line from the bottom of the right-hand column should have read "95 percent confidence interval, 0.40 to 1.50; P=0.45)," not "P=0.54," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.